Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review
- PMID: 17526629
- PMCID: PMC2696890
- DOI: 10.1093/alcalc/agm022
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review
Abstract
Aims: We conducted a review of published reports of smoking cessation pharmacotherapy trials in order to address the following: (i) the generalizability of findings to smokers with a history of alcohol problems; (ii) the extent to which alcohol use affects smoking cessation overall and the efficacy of pharmacotherapy specifically and (iii) the effect of smoking cessation on alcohol use.
Methods: We located published reports of nicotine replacement therapy (NRT), bupropion sustained release (SR) and varenicline clinical trials using an approach based on prior Cochrane reviews. The reports were searched for alcohol-related inclusion/exclusion criteria and for findings related to alcohol.
Results: The present review included 212 published reports from 149 trials. Alcohol-related exclusion criteria appeared frequently (41.6% of trials)--45/125 NRT trials (36%), 15/22 bupropion SR trials (68.2%) and 3/3 varenicline trials--and most commonly involved exclusion of participants with either current or recent alcohol problems. Most studies failed to provide any baseline alcohol-related characteristics. Eleven trials reported on the relationship between alcohol history and likelihood of smoking cessation. In the majority of these studies, smokers with a past history of alcohol problems were not at a disadvantage, although contrary findings exist. Only two studies examined the potential influence of smoking cessation on alcohol use.
Conclusions: Smokers with alcohol problems, particularly those with current or recent problems, are underrepresented in studies of approved pharmacotherapy for smoking cessation. Future trials should assess alcohol use at baseline and during treatment and examine reciprocal influences between alcohol consumption and smoking cessation.
Similar articles
-
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Cochrane Database Syst Rev. 2013. PMID: 23728690 Free PMC article. Review.
-
Interventions for smoking cessation and reduction in individuals with schizophrenia.Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD007253. doi: 10.1002/14651858.CD007253.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450574 Free PMC article. Review.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. PMID: 21328282 Updated. Review.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. PMID: 21154363 Updated. Review.
-
Varenicline: a first-line treatment option for smoking cessation.Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Clin Ther. 2009. PMID: 19393839 Review.
Cited by
-
Rate and correlates of tobacco treatment during a primary care visit for a largely urban and African American sample of smokers.Drug Alcohol Depend Rep. 2021 Nov 19;1:100006. doi: 10.1016/j.dadr.2021.100006. eCollection 2021 Dec. Drug Alcohol Depend Rep. 2021. PMID: 36843905 Free PMC article.
-
Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders.Tob Control. 2023 Jul;32(4):489-496. doi: 10.1136/tobaccocontrol-2021-056843. Epub 2021 Dec 3. Tob Control. 2023. PMID: 34862325 Free PMC article. Review.
-
Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.J Stud Alcohol Drugs. 2020 Jul;81(4):426-435. doi: 10.15288/jsad.2020.81.426. J Stud Alcohol Drugs. 2020. PMID: 32800078 Free PMC article.
-
Psychiatric comorbidities in a comparative effectiveness smoking cessation trial: Relations with cessation success, treatment response, and relapse risk factors.Drug Alcohol Depend. 2020 Feb 1;207:107796. doi: 10.1016/j.drugalcdep.2019.107796. Epub 2019 Dec 12. Drug Alcohol Depend. 2020. PMID: 31864163 Free PMC article.
-
Level of Alcohol Consumption and Successful Smoking Cessation.Nicotine Tob Res. 2019 Jul 17;21(8):1058-1064. doi: 10.1093/ntr/nty142. Nicotine Tob Res. 2019. PMID: 29986105 Free PMC article.
References
-
- Acheson A, Mahler SV, Chi H, de Wit H. Differential effects of nicotine on alcohol consumption in men and women. Psychopharmacology. 2006;186:54–63. - PubMed
-
- Ahluwalia JS, Harris KJ, Catley D, et al. Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. JAMA. 2002;288:468–474. - PubMed
-
- Aubin HJ, Lebargy F, Berlin I, et al. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Addiction. 2004;99:1206–18. - PubMed
-
- Batra AB, Kingler K, Landfeldt B, et al. Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study. Clinical Pharmacology and Therapeutics. 2005;78:689–96. - PubMed
-
- Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. Journal of Consulting and Clinical Psychology. 2004;72:371–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 AA015632/AA/NIAAA NIH HHS/United States
- T32 DA007238-15/DA/NIDA NIH HHS/United States
- K05 AA014715-04/AA/NIAAA NIH HHS/United States
- P50AA015632/AA/NIAAA NIH HHS/United States
- K05AA014715/AA/NIAAA NIH HHS/United States
- T32 DA007238/DA/NIDA NIH HHS/United States
- K05 AA014715-03/AA/NIAAA NIH HHS/United States
- P50 AA015632-08/AA/NIAAA NIH HHS/United States
- P50 AA015632-07/AA/NIAAA NIH HHS/United States
- T32 DA07238/DA/NIDA NIH HHS/United States
- T32 DA007238-16/DA/NIDA NIH HHS/United States
- K05 AA014715/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous